CA2273808A1 — Method and apparatus for granulating bee wax
Assigned to Individual · Expires 2000-12-09 · 25y expired
What this patent protects
Method and apparatus is described for producing bee wax particles to be used in pharmaceutical or cosmetics industry. Molten wax is fed from the top of an upright column downwards, against a counterflow of a cooling air whereby the molten wax solidifies into small particles. The …
USPTO Abstract
Method and apparatus is described for producing bee wax particles to be used in pharmaceutical or cosmetics industry. Molten wax is fed from the top of an upright column downwards, against a counterflow of a cooling air whereby the molten wax solidifies into small particles. The method and the apparatus include provision for controlling and/or monitoring the following variables: (i) the velocity of cooling air flowing through the column; (ii) the temperature of cooling air at its entering into the column; (iii) the temperature of air discharged from the column; (iv) the temperature of the wax at its entrance into the column.
Drugs covered by this patent
- OxyContin (oxycodone) · Purdue Pharma
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.